| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.52B | +19.4% |
| Cost of Revenue | $536.1M | +14.9% |
| Gross Profit | $1.98B | +20.7% |
| R&D Expense | $480.6M | +22.2% |
| SG&A Expense | $316.2M | +35.9% |
| Operating Income | -$88.0M | -42.3% |
| Interest Expense | $6.4M | -0.8% |
| Pre-tax Income | -$89.9M | -34.3% |
| Income Tax | $7.6M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $721.9M | +41.8% |
| Accounts Receivable | $516.9M | +17.2% |
| Current Assets | $1.63B | +23.6% |
| Total Assets | $3.01B | +18.6% |
| Current Liabilities | $2.21B | +61.0% |
| Total Liabilities | $2.40B | +5.7% |
| Stockholders' Equity | $617.3M | +124.1% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $506.8M | +0.1% |
| Capital Expenditures | $77.7M | +26.5% |
| Investing Cash Flow | -$191.2M | -17.4% |
| Financing Cash Flow | -$98.3M | +75.1% |
| Free Cash Flow | $429.1M | -3.6% |
| +147.3% |
| Net Income | -$97.5M | -39.3% |
| EPS (Basic) | -$0.49 | -36.1% |
| EPS (Diluted) | -$0.49 | -36.1% |